5% Minoxidil: treatment for female pattern hair loss

Skin Therapy Lett. Nov-Dec 2014;19(6):5-7.

Abstract

Minoxidil is a Health Canada and US FDA-approved medication for hair loss in men and women. While 5% minoxidil foam has been approved for men since 2006, Health Canada and the FDA only approved 5% minoxidil foam for female pattern hair loss (FPHL) in 2014. Recent Phase III clinical trials demonstrated the efficacy of once daily 5% minoxidil foam for treatment of FPHL, where a significant change from baseline in the target area hair count was observed compared to placebo. Similar changes in hair count for 5% foam and twice daily 2% minoxidil solution established noninferiority of the 5% foam formulation. Five percent minoxidil foam provides an additional option for women with FPHL and will soon be available in Canada.

Publication types

  • Review

MeSH terms

  • Alopecia / drug therapy*
  • Canada
  • Drug Administration Schedule
  • Female
  • Humans
  • Minoxidil / therapeutic use*
  • Randomized Controlled Trials as Topic

Substances

  • Minoxidil